Data availability
Novartis is committed to sharing access to patient-level data and supporting clinical documents from eligible studies with qualified external researchers. These requests will be reviewed and approved by an independent review panel based on scientific merit. All data provided will be anonymized to respect the privacy of patients who have participated in the trial, consistent with applicable laws and regulations. This trial data availability follows the criteria and process described at 